Cisplatin ototoxicity in the guinea pig: Vestibular and cochlear damage

Hearing Research

Volumn 182, Issue 1-2, 2003, Pages 56-64

  Sergi, Bruno ^a   Ferraresi, Aldo ^a   Troiani, Diana ^a   Paludetti, Gaetano ^a   Fetoni, Anna Rita ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cisplatin; Cochlear hair cell; Compound action potential; Inner ear; Ototoxicity; Vestibular hair cell; Vestibular ocular reflex

Indexed keywords

CISPLATIN; SODIUM CHLORIDE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; COCHLEAR DAMAGE; CONFERENCE PAPER; CONTROLLED STUDY; CORTI ORGAN; EARDRUM; EVOKED RESPONSE; FEMALE; GUINEA PIG; HAIR CELL; INNER EAR DISEASE; MORPHOLOGY; NEUROEPITHELIUM; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VESTIBULAR DISORDER; VESTIBULAR FUNCTION; VESTIBULOOCULAR REFLEX;

EID: 0042967906     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(03)00142-4     Document Type: Conference Paper

References (50)

1. Appenroth D., Winnefeld K. Role of glutathione for cisplatin nephrotoxicity in young and adult rats. Ren. Fail. 15:1993;135-139.
2. Aran, J.M., Erre, J.P., Guilhaume, A., Aurousseau, C., 1982. The comparative ototoxicities of gentamicin, tobramycin and debekacin in the guinea pig. A functional and morphological cochlear and vestibular study. Acta Otolaryngol. (Stockh.) Suppl. 390.
3. Bamonte F., Monopoli E., Orgini F., Sabetta F., Ferraresi A., Pettorossi V.E. Comparative actions of four aminoglycoside antibiotics on the vestibular function in guinea pigs. Arch. Int. Pharmacodyn. Ther. 282:1986;161-176.
4. Barmack N.H. A comparison of the horizontal and vertical vestibulo-ocular reflexes of the rabbit. J. Physiol. 314:1981;547-564.
5. Barmack, N.H., Pettorossi, V.E., 1981. The influences of head orientation and bilateral semicircular canal plugs upon the vertical vestibulo-ocular reflex in the rabbit. In: Gualtierotti, T. (Ed.), The Vestibular System: Function and Morphology. Springer Verlag, New York, pp. 491-508.
6. Black F.O., Myers E.N., Schramm V.L., Johnson J., Sigler B., Thearle P.B., Burns D.S. Cisplatin vestibular ototoxicity: preliminary results. Laryngoscope. 92:1982;1363-1368.
7. Black F.O., Gianna-Poulin C., Pesznecker S.C. Recovery from vestibular ototoxicity. Otol. Neurotol. 22:2001;662-671.
8. Blakely B.W., Gupta A.K., Myers S.F., Schwan S. Risk factors for ototoxicity due to cisplatin. Arch Otolaryngol. Head Neck Surg. 120:1994;541-546.
9. Cardinaal R.M., de Groot H.C.M.J., Huizing E.H., Veldman J.E., Smoorenburg G.F. Dose-dipendent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea. Hear. Res. 144:2000;135-146.
10. Clerici W.J., Hensley K., DiMartino D.L., Butterfield D.A. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear. Res. 98:1996;116-124.
11. Estrem S.A., Babin R.W., Ryu J.H., Moore K.C. Cis-diamminedichloroplatinum(II) ototoxicity in the guinea pig. Otolaryngol. Head Neck Surg. 89:1981;638-645.
12. Fetoni, A.R., Wang, J., Guitton, M., Galli, J., Puel, J.L., 2001. Local application of STS prevents cisplatin induced hearing loss. In: Abstract XXXVIII Workshop on Inner Ear Biology, Rome, 1-4 September 2001.
13. Fetoni A.R., Sergi B., Scarano E., Paludetti G., Ferraresi A., Troiani D. Protective effects of α-tocopherol against gentamicin-induced oto-vestibulotoxicity: an experimental study. Acta Otolaryngol. 123:2003;192-197.
14. Ford M.S., Nie Z., Whitworth C., Rybak L.P., Ramkumar V. Up-regulation of adenosine receptors in the cochlea by cisplatin. Hear. Res. 111:1997;143-152.
15. Gabaizadeh R., Stecker H., Liu W., Kopke R., Malgrange B., Lefebvre P.P., Van de Water T.R. Protection of both auditory hair cells and auditory neurons from cisplatin induced damage. Acta Otolaryngol. (Stockh.). 117:1997;232-238.
16. Huang T., Cheng A.G., Stupak H., Liu W., Kim A., Staecker H., Lebebvre P.P., Malgrange B., Kopke R., Moonem G., Van de Water T.R. Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies. Int. J. Dev. Neurosci. 18:2000;259-270.
17. Igarashi M., Levy J.L., Jerger J. Comparative toxicity of netilmicin and gentamicin in squirrel monkeys. J. Infect. Dis. 137:1978;476-480.
18. Kobayashi H., Ohashi N., Watanabe Y., Mizukoshi K. Clinical features of cisplatin vestibulotoxicity and hearing loss. ORL J. Otorhinolaryngol. Relat. Spec. 49:1987;67-72.
19. Kopelman J., Budnick A.S., Sessions R.B., Kramer M.B., Wong G.Y. Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing. Laryngoscope. 98:1988;858-864.
20. Kopke R.D., Gabaizadeh R., Jacono A., Janaco A., Feghali J., Spray D., Garcia P., Steinman M., Malgrange B., Ruben R.J., Rybak L., Van de Water T.R. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. Am. J. Otol. 18:1997;559-571.
21. Kruman I., Bruce-Keller A.J., Bredesen D., Waeg G., Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced apoptosis. J. Neurosci. 17:1997;5089-5100.
22. Laurell G., Bagger-Sjöbäck D. Dose-dependent inner ear changes after i.v. administration of cisplatin. J. Otolaryngol. 20:1991;158-167.
23. Laurell G., Jungnelius U. High-dose cisplatin treatment: hearing loss and plasma concentrations. Laryngoscope. 100:1990;724-734.
24. Miller G.H., Arcieri G., Weistein N.M., Waitz J.A. Biological activity of netilmicin, a broad spectrum semisynthetic aminoglycoside antibiotic. Antimicrob. Agents Chemother. 10:1976;827-836.
25. Myers S.F., Blakley B.W., Schwan S. Is cis-platinum vestibulotoxic? Otolaryngol. Head Neck Surg. 108:1993;322-328.
26. Nakayama M., Riggs L.C., Matz G.J. Quantitative study of vestibulotoxicity induced by gentamicin or cisplatin in the guinea pig. Laryngoscope. 106:1996;162-167.
27. Parravicini L., Arpini A., Bamonte F., Marzanatti M., Ongini E. Comparative ototoxicity of amikacin, gentamicin, netilmicin, and tobramicin in guinea pigs. Toxicol. Appl. Pharmacol. 65:1982;222-230.
28. Pettorossi V.E., Bamonte F., Errico P., Ongini E., Draicchio F., Sabetta F. Vestibulo-ocular reflex (VOR) in guinea pigs. Acta Otolaryngol. (Stockh.). 101:1986;378-388.
29. Pettorossi E.V., Ferraresi A., Errico P., Draicchio F., Dionisotti S. The impact of different dosing regimens of animoglycosides netilmicin and amikacin on vestibulotoxicity in the guinea pig. Eur. Arch. Otolaryngol. 247:1990;277-282.
30. Prim M.P., de Diego J.I., de Sarria M.J., Galivan J. Vestibular and oculomotor changes in subjects treated with cisplatin. Acta Otorrinolaringol. Esp. 52:2001;367-370.
31. Ravi R., Somani S.M., Rybak L.P. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol. Toxicol. 76:1995;386-394.
32. Rubel E.W., Dew L.A., Roberson D.W. Mammalian vestibular hair cell regeneration. Science. 267:1995;701-703.
33. Rybak L.P., Husain K., Evenson L., Morris C., Whitworth C., Somani S.M. Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system. Pharmacol. Toxicol. 81:1997;173-179.
34. Safirstein R., Winston J., Goldstein M., Moel D., Dikman S., Guttenplan J. Cisplatin nephrotoxicity. Am. J. Kidney Dis. 8:1986;356-367.
35. Sakamoto M., Kaga K., Kamio T. Extended high-frequency ototoxicity induced by the first administration of cisplatin. Otolaryngol. Head Neck Surg. 122:2000;828-833.
36. Schaefer S.D., Wright C.G., Post J.D., Frenkel E.P. Cis-platinum vestibular toxicity. Cancer. 47:1981;857-859.
37. Schaefer S.D., Post J.D., Close L.G., Wright C.G. Ototoxicity of low- and moderate-dose cisplatin. Cancer. 56:1985;1934-1939.
38. Schweitzer V.G. Ototoxicity of chemotherapeutic agents. Otolaryngol. Clin. North Am. 26:1993;759-789.
39. Schweitzer V.G. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. Laryngoscope. 103:(Suppl. 59):1993;1-52.
40. Schweitzer V.G., Hawkins J.E., Lilly D.J., Litterst C.J., Abrams G., David J.A., Christy M. Ototoxic and nephrotoxic effects of combined treatment with cis-diamminedichloroplatinum and kanamycin in the guinea pig. Otolaryngol. Head Neck Surg. 92:1984;38-49.
41. Schweitzer V.G., Rarey K.E., Dolan D.F., Abrams G.E., Sheridan C. Vestibular morphological analysis of the effects of cisplatin vs. platinum analogs, CBDCA (JM-8) and CHIP (JM-9). Laryngoscope. 96:1986;959-974.
42. Steng C.H.M., Klis S.F.L., Huizing E.H., Smoorenburg G.F. Cisplatin ototoxicity. An electrophysiological dose-effect study in albino guinea pigs. Hear. Res. 124:1998;99-107.
43. Strauss M., Towfighi J., Lord S., Lipton A., Harvey H.A., Brown B. Cis-platinum ototoxicity: clinical experience and temporal bone histopathology. Laryngoscope. 93:1983;1554-1559.
44. Tange R.A., Vuzevski V.D. Changes of the stria vascularis of the guinea pigs due to cisplatinum. Arch. Otorhinolaryngol. 239:1984;41-47.
45. Tsukasaki N., Whitworth C.A., Rybak L.P. Acute changes in cochlear potentials due to cisplatin. Hear. Res. 149:2000;189-198.
46. Vermorken J.B., Kapteijn T.S., Hart A.A., Pinedo H.M. Ototoxicity of cis-diamminedichloroplatinum(II): influence of dose, schedule and mode of administration. Eur. J. Cancer Clin. Oncol. 19:1983;53-58.
47. Watanabe K., Hess A., Bloch W., Michel O. Expression of inducible nitric oxide synthase (iNOS/NOS II) in the vestibule of guinea pigs after the application of cisplatin. Anticancer Drugs. 11:2000;29-32.
48. Watanabe K., Jinnouchi K., Baba S., Yagi T. Induction of apoptotic pathway in the vestibule of cisplatin (CDDP)-treated guinea pigs. Anticancer Res. 21:2001;3929-3932.
49. Wright C.G., Schaefer S.D. Inner ear histopathology in patients treated with cis-platinum. Laryngoscope. 92:1982;1408-1413.
50. Zheng J.L., Gao W.Q. Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures. Eur. J. Neurosci. 8:1996;1897-1905.